2025 Q4 -tulosraportti
Äänite tulossa
Tänään
Tarjoustasot
First North Sweden
Määrä
Osto
5 500
Myynti
Määrä
7 756
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 400 | - | - | ||
| 30 | - | - | ||
| 1 244 | - | - | ||
| 300 | - | - | ||
| 16 | - | - |
Ylin
1,385VWAP
Alin
1,3VaihtoMäärä
0 27 542
VWAP
Ylin
1,385Alin
1,3VaihtoMäärä
0 27 542
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 4.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·23.12.2025It's expensive to be poor. They got 81 % of the shares subscribed, including shares subscribed without subscription rights. A bit low considering the share was at 2 sek before the emission. Should have been almost "free money" / arbitrage. 20 mio in. 1,1 msek to the guarantor. And probably 1 mio for other costs related to the emission. (Don't have the stated figure at hand). So approx 10 % in transaction costs. Now it will be exciting if the share moves up.
·23.12.2025It will be slow until one day there is a valuable unlisted share that is listed on the stock exchange. But if one has time and can afford to be long-term, and can live with an illiquid share, then I personally think this is a good bet, and have bought up accordingly at the issuance. According to the analysis below 12.12.2025- ·12.12.202512-12-25 Update of real intrinsic value after issue. The issue result was satisfactory – given the assumptions. And we avoided shares sold to guarantors at a discount and subsequent price pressure. So now we can look forward again. With the current offer price of 1,38 SEK, one effectively gets the entire unlisted share portfolio quite free. My assumptions are the following: Full issue 18 mio. after costs. Of which 8 mio. in cash holdings and 10 mio. invested in new unlisted shares. And CombiQ adjusted down to 12 mio. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) The real intrinsic value discount currently is thus 99 %. After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know that, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. (Even if the latter is the case in this share – and is generally positive – I have conversely written previously that precisely in this share I might be a little concerned that it could one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies will together “only” constitute approx. 45 % of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment. As a result of the issue, the expense naturally falls proportionally when distributed over more shares. Apart from the above, the issue has fundamentally not changed anything. The price has just plummeted - and the discount has increased. The issue was not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet, as if it were a biotech share issue, instead of having carried out a directed issue. Right now there is a bargain offer on the share – and as always an extra discount on the BTA before the consolidation of shares. But if one is not long-term, one should be aware that the share is normally not very liquid. (With this update, previous versions are deleted.)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Äänite tulossa
Tänään
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23.12.2025It's expensive to be poor. They got 81 % of the shares subscribed, including shares subscribed without subscription rights. A bit low considering the share was at 2 sek before the emission. Should have been almost "free money" / arbitrage. 20 mio in. 1,1 msek to the guarantor. And probably 1 mio for other costs related to the emission. (Don't have the stated figure at hand). So approx 10 % in transaction costs. Now it will be exciting if the share moves up.·23.12.2025It will be slow until one day there is a valuable unlisted share that is listed on the stock exchange. But if one has time and can afford to be long-term, and can live with an illiquid share, then I personally think this is a good bet, and have bought up accordingly at the issuance. According to the analysis below 12.12.2025
- ·12.12.202512-12-25 Update of real intrinsic value after issue. The issue result was satisfactory – given the assumptions. And we avoided shares sold to guarantors at a discount and subsequent price pressure. So now we can look forward again. With the current offer price of 1,38 SEK, one effectively gets the entire unlisted share portfolio quite free. My assumptions are the following: Full issue 18 mio. after costs. Of which 8 mio. in cash holdings and 10 mio. invested in new unlisted shares. And CombiQ adjusted down to 12 mio. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) The real intrinsic value discount currently is thus 99 %. After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know that, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. (Even if the latter is the case in this share – and is generally positive – I have conversely written previously that precisely in this share I might be a little concerned that it could one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies will together “only” constitute approx. 45 % of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment. As a result of the issue, the expense naturally falls proportionally when distributed over more shares. Apart from the above, the issue has fundamentally not changed anything. The price has just plummeted - and the discount has increased. The issue was not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet, as if it were a biotech share issue, instead of having carried out a directed issue. Right now there is a bargain offer on the share – and as always an extra discount on the BTA before the consolidation of shares. But if one is not long-term, one should be aware that the share is normally not very liquid. (With this update, previous versions are deleted.)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
5 500
Myynti
Määrä
7 756
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 400 | - | - | ||
| 30 | - | - | ||
| 1 244 | - | - | ||
| 300 | - | - | ||
| 16 | - | - |
Ylin
1,385VWAP
Alin
1,3VaihtoMäärä
0 27 542
VWAP
Ylin
1,385Alin
1,3VaihtoMäärä
0 27 542
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 4.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
2025 Q4 -tulosraportti
Äänite tulossa
Tänään
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 4.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 15.5.2025 | ||
2024 Q4 -tulosraportti 20.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23.12.2025It's expensive to be poor. They got 81 % of the shares subscribed, including shares subscribed without subscription rights. A bit low considering the share was at 2 sek before the emission. Should have been almost "free money" / arbitrage. 20 mio in. 1,1 msek to the guarantor. And probably 1 mio for other costs related to the emission. (Don't have the stated figure at hand). So approx 10 % in transaction costs. Now it will be exciting if the share moves up.·23.12.2025It will be slow until one day there is a valuable unlisted share that is listed on the stock exchange. But if one has time and can afford to be long-term, and can live with an illiquid share, then I personally think this is a good bet, and have bought up accordingly at the issuance. According to the analysis below 12.12.2025
- ·12.12.202512-12-25 Update of real intrinsic value after issue. The issue result was satisfactory – given the assumptions. And we avoided shares sold to guarantors at a discount and subsequent price pressure. So now we can look forward again. With the current offer price of 1,38 SEK, one effectively gets the entire unlisted share portfolio quite free. My assumptions are the following: Full issue 18 mio. after costs. Of which 8 mio. in cash holdings and 10 mio. invested in new unlisted shares. And CombiQ adjusted down to 12 mio. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) The real intrinsic value discount currently is thus 99 %. After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know that, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. (Even if the latter is the case in this share – and is generally positive – I have conversely written previously that precisely in this share I might be a little concerned that it could one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares occupy in the portfolio. In this share, the 3 largest unlisted companies will together “only” constitute approx. 45 % of the unlisted shares. So that does not worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment. As a result of the issue, the expense naturally falls proportionally when distributed over more shares. Apart from the above, the issue has fundamentally not changed anything. The price has just plummeted - and the discount has increased. The issue was not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet, as if it were a biotech share issue, instead of having carried out a directed issue. Right now there is a bargain offer on the share – and as always an extra discount on the BTA before the consolidation of shares. But if one is not long-term, one should be aware that the share is normally not very liquid. (With this update, previous versions are deleted.)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
5 500
Myynti
Määrä
7 756
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 400 | - | - | ||
| 30 | - | - | ||
| 1 244 | - | - | ||
| 300 | - | - | ||
| 16 | - | - |
Ylin
1,385VWAP
Alin
1,3VaihtoMäärä
0 27 542
VWAP
Ylin
1,385Alin
1,3VaihtoMäärä
0 27 542
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 27 542 | 27 542 | 0 | 0 |